Humeral Shaft Fracture Sustained During Arm Wrestling with Review of Factors Contributing to its Causation

Autor: Pande KC, Nishat NMH, Afzal SML, Ishak L

Publikováno v: Malaysian Orthopaedic Journal, Vol 15, Iss 3, Pp 15-20 (2021)

INTRODUCTION: Humeral shaft fractures are the most common injury sustained in arm wrestling, and its various biomechanical, anatomical, kinematic and electromyographic aspects have been studied and reported. We present a series of six cases of humera

Externí odkaz: https://doaj.org/article/89c903d182ff4e5f9ded6daf6c1563e1

Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY).

Autor: Horga A; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., Saenz R; Genentech, Inc, San Francisco, CA 94080, USA., Yilmaz G; Karadeniz Technical University, Trabzon, 61080, Turkey., Simón-Campos A; Köhler & Milstein Research, Anahuac-Mayab University, Mérida, 97308, Mexico., Pietropaolo K; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., Stubbings WJ; F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland., Collinson N; Roche Products Limited, Welwyn Garden City, AL7 1TW, Hertfordshire, UK., Ishak L; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., Zrinscak B; Roche Pharma Canada, Mississauga, ON, L5N 5M8, Ontario, Canada., Belanger B; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., Granier C; Roche Products Limited, Welwyn Garden City, AL7 1TW, Hertfordshire, UK., Lin K; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., C Hurt A; F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland., Zhou XJ; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA., Wildum S; F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland., Hammond J; Atea Pharmaceuticals, Inc, Boston, MA 02110, USA.

Publikováno v: Future virology [Future Virol] 2023 Oct. Date of Electronic Publication: 2023 Nov 01.

NUDT6 and NUDT9, two mitochondrial members of the NUDIX family, have distinct hydrolysis activities.

Autor: Debar L; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Ishak L; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Moretton A; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Anoosheh S; Umeå University, Department of Medical Biochemistry and Biophysics, SE-90187 Umeå, Sweden., Morel F; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Jenninger L; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Garreau-Balandier I; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Vernet P; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Hofer A; Umeå University, Department of Medical Biochemistry and Biophysics, SE-90187 Umeå, Sweden., van den Wildenberg S; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS, IRD, Université Jean Monnet Saint Etienne, LMV, F-63000 Clermont-Ferrand, France., Farge G; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France. Electronic address: geraldine.farge@uca.fr.

Publikováno v: Mitochondrion [Mitochondrion] 2023 Jul; Vol. 71, pp. 93-103. Date of Electronic Publication: 2023 Jun 19.

Disease causing mutation (P178L) in mitochondrial transcription factor A results in impaired mitochondrial transcription initiation.

Autor: Mehmedović M; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Martucci M; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France., Spåhr H; Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm 17177, Sweden., Ishak L; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Mishra A; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Sanchez-Sandoval ME; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Pardo-Hernández C; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., Peter B; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden., van den Wildenberg SM; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS, IRD, Université Jean Monnet Saint Etienne, LMV, F-63000 Clermont-Ferrand, France., Falkenberg M; Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden. Electronic address: maria.falkenberg@medkem.gu.se., Farge G; Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, F-63000 Clermont-Ferrand, France. Electronic address: geraldine.farge@uca.fr.

Publikováno v: Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2022 Oct 01; Vol. 1868 (10), pp. 166467. Date of Electronic Publication: 2022 Jun 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.